Abstract:To evaluate the value of radiomics for survival analysis and prediction of glioblastoma (GBM) patients treated with chemoradiation therapy (CRT). Twenty-eight newly diagnosed GBM patients who received CRT at our institution between 2008 and 2014 were retrospectively studied. In addition to demographics (age, race, gender) and clinical parameters (KPS, extent of resection, radiation therapy type, dose and status, whether concurrent temozolomide was adjusted/stopped), 255 imaging features were extracted from 3 gadolinium-enhanced T1 weighted MRIs for 2 regions of interest (ROIs) (the surgical cavity and its surrounding enhancement rim). The 3 MRIs were at post-operation, 1-month and 3-month post-CRT. For the radiomics approach, imaging features comprehensively quantified the intensity, spatial variation (texture), geometric property, and their spatial-temporal changes for the 2 ROIs. Overall survival (OS) and progression-free survival (PFS) were analyzed using univariate and multivariate analysis. Machine learning models (logistic regression (LR), support vector machine (SVM), decision tree (DT), neural network (NN)) were applied to evaluate the survival prediction capability of algorithmically selected features. The number of cases and percentage of cases predicted correctly were collected and AUC (area under the receiver operating characteristic (ROC) curve) were determined after leave-one-out cross-validation. For univariate survival analysis, 28 features (1 demographic, 2 clinical and 25 imaging) were statistically significant (P<0.05) for both OS and PFS. The types of imaging features were volumetric, intensity, geometry, texture and their spatial-temporal changes. For multivariate survival analysis, 14 of the features remained statistically significant (P<0.05) for OS and 20 features remained statistically significant (P<0.01) for PFS. When all the features were used by machine learning models to predict the survival, 24 features were algorithmically selected. High prediction accuracy of OS was achieved by using NN (96%, 27 of 28 cases were correctly predicted, AUC = 0.99), LR (93%, 26 of 28 cases were correctly predicted, AUC = 0.95) and SVM (93%, 26 of 28 cases were correctly predicted, AUC = 0.90). When predicting PFS, NN obtained the highest prediction accuracy (89%, 25 of 28 cases were correctly predicted, AUC = 0.92). In this preliminary study, radiomics approach combined with patients’ demographics and clinical parameters are promising (even MGMT status was not available) for survival analysis and prediction in GBM patients treated with CRT. To achieve more accurate predictions, advanced machine learning models should be considered.

Survival Prediction Analysis in Glioblastoma With Diffusion Kurtosis Imaging

Whole Brain Atlas-Based Diffusion Kurtosis Imaging Parameters for the Evaluation of Multiple Cognitive-Related Brain Microstructure Injuries after Radiotherapy in Lung Cancer Patients with Brain Metastasis

Radiomics Analysis of Diffusion Kurtosis Imaging: Distinguishing Between Glioblastoma and Single Brain Metastasis

Diffusion Kurtosis Imaging Can Efficiently Assess the Glioma Grade and Cellular Proliferation

Diffusion kurtosis imaging in evaluating gliomas: different region of interest selection methods on time efficiency, measurement repeatability, and diagnostic ability

Developing a Predictive Grading Model for Children with Gliomas Based on Diffusion Kurtosis Imaging Metrics: Accuracy and Clinical Correlations with Patient Survival

Application of diffusion kurtosis imaging to the study of edema in solid and peritumoral areas of glioma

Diffusion Kurtosis Imaging As a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy.

Two Diffusion Kurtosis Imaging Post-Processing Methods for Differentiating Glioma Grades, IDH Mutation Statuses, and Heterogeneity

Diffusion heterogeneity and vascular perfusion in tumor and peritumoral areas for prediction of overall survival in patients with high-grade glioma

DWI in survival prediction for patients with glioblastoma receiving chemoradiotherapy

The diagnostic role of diffusional kurtosis imaging in glioma grading and differentiation of gliomas from other intra-axial brain tumours: a systematic review with critical appraisal and meta-analysis

Evaluation of Diffuse Glioma Grade and Proliferation Activity by Different Diffusion-Weighted-imaging Models Including Diffusion Kurtosis Imaging (DKI) and Mean Apparent Propagator (MAP) MRI.

Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma

Radiomics for Survival Analysis and Prediction in Glioblastoma (GBM)—A Preliminary Study

Diffusion Kurtosis Imaging in Assessment of Gastric Cancer Aggressiveness

Prognostic Value of Pretreatment MRI Texture Features in Breast Cancer Brain Metastasis Treated with Gamma Knife Radiosurgery

Evaluation of Cerebral Glioma Using 3T Diffusion Kurtosis Tensor Imaging and the Relationship Between Diffusion Kurtosis Metrics and Tumor Cellularity

Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance

Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors.

Cluster Analysis of DSC MRI, Dynamic Contrast-Enhanced MRI, and DWI Parameters Associated with Prognosis in Patients with Glioblastoma after Removal of the Contrast-Enhancing Component: A Preliminary Study